title: Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective.
abstract: Glycoprotein IIb/IIIa antagonists have been shown to be effective in reducing thrombotic complications prior to high-risk coronary interventions. Some studies have reported improved coronary flow after abciximab in slow or no-reflow phenomenon. We report a case in which abciximab did not clear the thrombotic occlusion or restore artery flow. Further studies are needed into the refractory no-flow phenomenon.
authors.affiliation: Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel.
authors.forename: Shmuel
authors.initials: S
authors.lastname: Banai
authors.forename: Aharon
authors.initials: A
authors.lastname: Medina
authors.forename: Andre
authors.initials: A
authors.lastname: Keren